Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Colombia | 13.1 Narcotic Analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) | No observations |
| Training CSamouge 2022 | 2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) | No observations |
| WHO Model List of Essential Medicines (2021) | 29.3. Juvenile joint diseases |
Others observations: For use for rheumatic fever, juvenile arthritis, Kawasaki disease. Acute or chronic use. |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 29.3. Juvenile joint diseases | No observations |
| WHO Model List of Essential Medicines (2021) | 2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) | No observations |
| WHO Model List of Essential Medicines (2021) | 29.3. Juvenile joint diseases | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) | No observations |
| Bolivia | LINAME 2011 - 2013 | No observations |
| Training CSamouge 2022 | 2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) | No observations |
| WHO Model List of Essential Medicines (2021) | 29.3. Juvenile joint diseases |
Others observations: For use for rheumatic fever, juvenile arthritis, Kawasaki disease. Acute or chronic use. |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 7.1. For treatment of acute attack | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.5.1 Anti-platelet medicines | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| Colombia | 13.2 Non-Narcotic Analgesics | No observations |
| Venezuela (incomplete) | List of Generic Medications - Venezuela | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 29.3. Juvenile joint diseases | No observations |
| WHO Model List of Essential Medicines (2021) | 2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) | No observations |
| WHO Model List of Essential Medicines (2021) | 7.1. For treatment of acute attack | No observations |
| Peru | 2.1 Non-Opiate Analgesics and Non-Steroidal Anti-Inflammatories (NSAIDs) | No observations |
| Peru | 7.1 For Treatment of Acute Attacks | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| Colombia | 13.2 Non-Narcotic Analgesics | No observations |
| Venezuela (incomplete) | List of Generic Medications - Venezuela | No observations |
| Cuba | 2.1 Analgésicos no opioides | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 12.5 Anti-Thrombotics | No observations |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 29.3. Juvenile joint diseases | No observations |
| WHO Model List of Essential Medicines (2021) | 2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) | No observations |
| WHO Model List of Essential Medicines (2021) | 7.1. For treatment of acute attack | No observations |